Carcinotech

Private

EdinburghHealthcare & Life Scienceshttps://www.carcinotech.com/

Last Round

Early Funding

Jan 29, 2024

Total Funding Raised

$7.4M

Company Overview

Carcinotech is a medical technology company that provides 3D printed living tumors using patient-derived biopsies for drug screening, pre-clinical testing, and personalized medicine.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, 3D Printing, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

3D bioprintingtumor modelscontract research organizationCROoncology drug discoverypreclinical testingpersonalized medicineorgan-on-a-chipin vitro modelsdrug screeningtumor microenvironmentpatient-derived cellsbiotech servicestranslational researchlab-on-a-chip

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Carcinotech Comps

Public and private peers based on sector, stage, and business model.

Carcinotech comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Carcinotech Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Early Funding	Jan 29, 2024
Seed	Apr 25, 2022

View all Funding Rounds

Key People

Founding team and executive leadership

Lorna Ewart

Chief Executive Officer, Non Executive Director

Executive Team

Lorna Peers FCCA

Chief Financial Officer

Executive Team

Carcinotech Investors

Notable investors and investment history

Carcinotech investors
Investor	Rounds
Investing Women Angels	Early Funding
Gabriel Investments Ltd	Early Funding, Seed
British Business Bank	Early Funding
Old College Capital	Early Funding, Pre Seed
The TRICAPITAL Syndicate	Early Funding, Seed
Eos Advisory	Seed, Early Funding
Gabriel Investments	Seed

View all Investors

Carcinotech Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Carcinotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Carcinotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersEdinburgh

Employee Range11

Year Founded2018

Last FundingJan 29, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.